Loading...
Bavarian Nordic A/S
BVNRY•PNK
Healthcare
Biotechnology
$12.17
$0.04(0.33%)
Bavarian Nordic A/S (BVNRY) Financial Performance & Income Statement Overview
Review Bavarian Nordic A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-19.06%
↓ 19.06%
Operating Income Growth
-37.25%
↓ 37.25%
Net Income Growth
-33.03%
↓ 33.03%
Operating Cash Flow Growth
74.22%
↑ 74.22%
Operating Margin
21.30%
↑ 21.30%
Gross Margin
51.90%
↑ 51.90%
Net Profit Margin
21.20%
↑ 21.20%
ROE
11.99%
↑ 11.99%
ROIC
11.30%
↑ 11.30%
Bavarian Nordic A/S (BVNRY) Income Statement & Financial Overview
Review Bavarian Nordic A/S's (BVNRY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.09B | $1.36B | $1.43B | $831.47M |
| Cost of Revenue | $839.90M | $783.76M | $707.55M | $566.24M |
| Gross Profit | $1.25B | $579.60M | $719.95M | $265.24M |
| Gross Profit Ratio | $0.60 | $0.43 | $0.50 | $0.32 |
| R&D Expenses | $203.54M | $264.28M | $209.59M | $185.11M |
| SG&A Expenses | $341.24M | $221.75M | $244.47M | $209.02M |
| Operating Expenses | $544.77M | $486.03M | $454.06M | $394.13M |
| Total Costs & Expenses | $1.38B | $1.27B | $1.16B | $960.37M |
| Interest Income | $12.59M | $9.36M | $9.55M | $16.81M |
| Interest Expense | $11.24M | $23.48M | $21.39M | $21.76M |
| Depreciation & Amortization | $202.10M | $156.89M | $153.65M | $150.73M |
| EBITDA | $921.91M | $252.84M | $441.03M | $58.35M |
| EBITDA Ratio | $0.44 | $0.19 | $0.31 | $0.07 |
| Operating Income | $709.20M | $93.57M | $265.89M | -$128.90M |
| Operating Income Ratio | $0.34 | $0.07 | $0.19 | -$0.16 |
| Other Income/Expenses (Net) | $37.85M | -$21.11M | $97000.00 | $14.75M |
| Income Before Tax | $747.05M | $72.46M | $265.99M | -$114.14M |
| Income Before Tax Ratio | $0.36 | $0.05 | $0.19 | -$0.14 |
| Income Tax Expense | -$23.76M | $1.97M | $4.86M | $310000.00 |
| Net Income | $770.81M | $70.49M | $261.13M | -$114.45M |
| Net Income Ratio | $0.37 | $0.05 | $0.18 | -$0.14 |
| EPS | $9.84 | $0.90 | $3.30 | -$1.50 |
| Diluted EPS | $9.84 | $0.90 | $3.30 | -$1.50 |
| Weighted Avg Shares Outstanding | $78.57M | $78.32M | $79.13M | $76.30M |
| Weighted Avg Shares Outstanding (Diluted) | $78.57M | $78.32M | $79.13M | $76.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan